Cellink Ab Stock Today
| CLLKF Stock | USD 2.21 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressHigh
|
Cellink AB is trading at 2.21 as of the 24th of November 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 2.21. Cellink AB has more than 69 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 26th of August 2025 and ending today, the 24th of November 2025. Click here to learn more.
BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States. The company has 69.07 M outstanding shares. More on Cellink AB
Moving against Cellink Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cellink Pink Sheet Highlights
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Cellink AB [CLLKF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 657.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cellink AB's market, we take the total number of its shares issued and multiply it by Cellink AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cellink AB classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 69.07 M outstanding shares.
Cellink AB generates negative cash flow from operations
Check Cellink AB Probability Of Bankruptcy
Ownership AllocationCellink AB holds a total of 69.07 Million outstanding shares. Cellink AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cellink Ownership Details
Cellink AB Risk Profiles
| Mean Deviation | 1.85 | |||
| Standard Deviation | 4.12 | |||
| Variance | 16.96 | |||
| Risk Adjusted Performance | (0.04) |
Cellink Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cellink AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Cellink AB Corporate Management
| Erik Gatenholm | CEO, CoFounder | Profile | |
| Lotta Bus | Gen SVP | Profile | |
| Karin Danielsson | Global Director | Profile | |
| Asa Hillsten | VP Relations | Profile | |
| Itedale Redwan | Chief Bioprinting | Profile | |
| Erica Bell | VP Officer | Profile | |
| Niclas Emanuelsson | Head Operations | Profile |
Other Information on Investing in Cellink Pink Sheet
Cellink AB financial ratios help investors to determine whether Cellink Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.